Global Human Albumin Injection Market Growth 2026-2032
The global Human Albumin Injection market size is predicted to grow from US$ 438 million in 2025 to US$ 620 million in 2032; it is expected to grow at a CAGR of 5.2% from 2026 to 2032.
Human albumin solutions are used in a range of medical and surgical problems.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
LP Information, Inc. (LPI) ' newest research report, the ?Human Albumin Injection Industry Forecast? looks at past sales and reviews total world Human Albumin Injection sales in 2025, providing a comprehensive analysis by region and market sector of projected Human Albumin Injection sales for 2026 through 2032. With Human Albumin Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Albumin Injection industry.
This Insight Report provides a comprehensive analysis of the global Human Albumin Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Human Albumin Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Human Albumin Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Albumin Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Albumin Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Albumin Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Human albumin solutions are used in a range of medical and surgical problems.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
LP Information, Inc. (LPI) ' newest research report, the ?Human Albumin Injection Industry Forecast? looks at past sales and reviews total world Human Albumin Injection sales in 2025, providing a comprehensive analysis by region and market sector of projected Human Albumin Injection sales for 2026 through 2032. With Human Albumin Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Albumin Injection industry.
This Insight Report provides a comprehensive analysis of the global Human Albumin Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Human Albumin Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Human Albumin Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Albumin Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Albumin Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Albumin Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Blood Extraction
- Recombine
- Hospital
- Clinic
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Octapharma
- CSL Behring
- Biotest (UK) Ltd
- Baxter
- Kedrion Biopharma, Inc.
- Grifols
- GE HealthCare
- Bio Products Laboratory
- Green Cross
- SK Plasma
- Instituto Grifols
- Takeda
- Hualan Bio
- Nanyue Biopharmaceuticals
- What is the 10-year outlook for the global Human Albumin Injection market?
- What factors are driving Human Albumin Injection market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Human Albumin Injection market opportunities vary by end market size?
- How does Human Albumin Injection break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Human Albumin Injection Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Human Albumin Injection by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Human Albumin Injection by Country/Region, 2021, 2025 & 2032
2.2 Human Albumin Injection Segment by Type
2.2.1 Blood Extraction
2.2.2 Recombine
2.2.3 Human Albumin Injection Sales by Type
2.2.3.1 Global Human Albumin Injection Sales Market Share by Type (2021-2026)
2.2.3.2 Global Human Albumin Injection Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Human Albumin Injection Sale Price by Type (2021-2026)
2.3 Human Albumin Injection Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Human Albumin Injection Sales by Application
2.3.3.1 Global Human Albumin Injection Sale Market Share by Application (2021-2026)
2.3.3.2 Global Human Albumin Injection Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Human Albumin Injection Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Human Albumin Injection Breakdown Data by Company
3.1.1 Global Human Albumin Injection Annual Sales by Company (2021-2026)
3.1.2 Global Human Albumin Injection Sales Market Share by Company (2021-2026)
3.2 Global Human Albumin Injection Annual Revenue by Company (2021-2026)
3.2.1 Global Human Albumin Injection Revenue by Company (2021-2026)
3.2.2 Global Human Albumin Injection Revenue Market Share by Company (2021-2026)
3.3 Global Human Albumin Injection Sale Price by Company
3.4 Key Manufacturers Human Albumin Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Albumin Injection Product Location Distribution
3.4.2 Players Human Albumin Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HUMAN ALBUMIN INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Human Albumin Injection Market Size by Geographic Region (2021-2026)
4.1.1 Global Human Albumin Injection Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Human Albumin Injection Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Human Albumin Injection Market Size by Country/Region (2021-2026)
4.2.1 Global Human Albumin Injection Annual Sales by Country/Region (2021-2026)
4.2.2 Global Human Albumin Injection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Human Albumin Injection Sales Growth
4.4 APAC Human Albumin Injection Sales Growth
4.5 Europe Human Albumin Injection Sales Growth
4.6 Middle East & Africa Human Albumin Injection Sales Growth
5 AMERICAS
5.1 Americas Human Albumin Injection Sales by Country
5.1.1 Americas Human Albumin Injection Sales by Country (2021-2026)
5.1.2 Americas Human Albumin Injection Revenue by Country (2021-2026)
5.2 Americas Human Albumin Injection Sales by Type (2021-2026)
5.3 Americas Human Albumin Injection Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Albumin Injection Sales by Region
6.1.1 APAC Human Albumin Injection Sales by Region (2021-2026)
6.1.2 APAC Human Albumin Injection Revenue by Region (2021-2026)
6.2 APAC Human Albumin Injection Sales by Type (2021-2026)
6.3 APAC Human Albumin Injection Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Human Albumin Injection by Country
7.1.1 Europe Human Albumin Injection Sales by Country (2021-2026)
7.1.2 Europe Human Albumin Injection Revenue by Country (2021-2026)
7.2 Europe Human Albumin Injection Sales by Type (2021-2026)
7.3 Europe Human Albumin Injection Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Human Albumin Injection by Country
8.1.1 Middle East & Africa Human Albumin Injection Sales by Country (2021-2026)
8.1.2 Middle East & Africa Human Albumin Injection Revenue by Country (2021-2026)
8.2 Middle East & Africa Human Albumin Injection Sales by Type (2021-2026)
8.3 Middle East & Africa Human Albumin Injection Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Albumin Injection
10.3 Manufacturing Process Analysis of Human Albumin Injection
10.4 Industry Chain Structure of Human Albumin Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Albumin Injection Distributors
11.3 Human Albumin Injection Customer
12 WORLD FORECAST REVIEW FOR HUMAN ALBUMIN INJECTION BY GEOGRAPHIC REGION
12.1 Global Human Albumin Injection Market Size Forecast by Region
12.1.1 Global Human Albumin Injection Forecast by Region (2027-2032)
12.1.2 Global Human Albumin Injection Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Human Albumin Injection Forecast by Type (2027-2032)
12.7 Global Human Albumin Injection Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Octapharma
13.1.1 Octapharma Company Information
13.1.2 Octapharma Human Albumin Injection Product Portfolios and Specifications
13.1.3 Octapharma Human Albumin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Octapharma Main Business Overview
13.1.5 Octapharma Latest Developments
13.2 CSL Behring
13.2.1 CSL Behring Company Information
13.2.2 CSL Behring Human Albumin Injection Product Portfolios and Specifications
13.2.3 CSL Behring Human Albumin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 CSL Behring Main Business Overview
13.2.5 CSL Behring Latest Developments
13.3 Biotest (UK) Ltd
13.3.1 Biotest (UK) Ltd Company Information
13.3.2 Biotest (UK) Ltd Human Albumin Injection Product Portfolios and Specifications
13.3.3 Biotest (UK) Ltd Human Albumin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Biotest (UK) Ltd Main Business Overview
13.3.5 Biotest (UK) Ltd Latest Developments
13.4 Baxter
13.4.1 Baxter Company Information
13.4.2 Baxter Human Albumin Injection Product Portfolios and Specifications
13.4.3 Baxter Human Albumin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Baxter Main Business Overview
13.4.5 Baxter Latest Developments
13.5 Kedrion Biopharma, Inc.
13.5.1 Kedrion Biopharma, Inc. Company Information
13.5.2 Kedrion Biopharma, Inc. Human Albumin Injection Product Portfolios and Specifications
13.5.3 Kedrion Biopharma, Inc. Human Albumin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Kedrion Biopharma, Inc. Main Business Overview
13.5.5 Kedrion Biopharma, Inc. Latest Developments
13.6 Grifols
13.6.1 Grifols Company Information
13.6.2 Grifols Human Albumin Injection Product Portfolios and Specifications
13.6.3 Grifols Human Albumin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Grifols Main Business Overview
13.6.5 Grifols Latest Developments
13.7 GE HealthCare
13.7.1 GE HealthCare Company Information
13.7.2 GE HealthCare Human Albumin Injection Product Portfolios and Specifications
13.7.3 GE HealthCare Human Albumin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 GE HealthCare Main Business Overview
13.7.5 GE HealthCare Latest Developments
13.8 Bio Products Laboratory
13.8.1 Bio Products Laboratory Company Information
13.8.2 Bio Products Laboratory Human Albumin Injection Product Portfolios and Specifications
13.8.3 Bio Products Laboratory Human Albumin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Bio Products Laboratory Main Business Overview
13.8.5 Bio Products Laboratory Latest Developments
13.9 Green Cross
13.9.1 Green Cross Company Information
13.9.2 Green Cross Human Albumin Injection Product Portfolios and Specifications
13.9.3 Green Cross Human Albumin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Green Cross Main Business Overview
13.9.5 Green Cross Latest Developments
13.10 SK Plasma
13.10.1 SK Plasma Company Information
13.10.2 SK Plasma Human Albumin Injection Product Portfolios and Specifications
13.10.3 SK Plasma Human Albumin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 SK Plasma Main Business Overview
13.10.5 SK Plasma Latest Developments
13.11 Instituto Grifols
13.11.1 Instituto Grifols Company Information
13.11.2 Instituto Grifols Human Albumin Injection Product Portfolios and Specifications
13.11.3 Instituto Grifols Human Albumin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Instituto Grifols Main Business Overview
13.11.5 Instituto Grifols Latest Developments
13.12 Takeda
13.12.1 Takeda Company Information
13.12.2 Takeda Human Albumin Injection Product Portfolios and Specifications
13.12.3 Takeda Human Albumin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Takeda Main Business Overview
13.12.5 Takeda Latest Developments
13.13 Hualan Bio
13.13.1 Hualan Bio Company Information
13.13.2 Hualan Bio Human Albumin Injection Product Portfolios and Specifications
13.13.3 Hualan Bio Human Albumin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Hualan Bio Main Business Overview
13.13.5 Hualan Bio Latest Developments
13.14 Nanyue Biopharmaceuticals
13.14.1 Nanyue Biopharmaceuticals Company Information
13.14.2 Nanyue Biopharmaceuticals Human Albumin Injection Product Portfolios and Specifications
13.14.3 Nanyue Biopharmaceuticals Human Albumin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Nanyue Biopharmaceuticals Main Business Overview
13.14.5 Nanyue Biopharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Human Albumin Injection Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Human Albumin Injection by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Human Albumin Injection by Country/Region, 2021, 2025 & 2032
2.2 Human Albumin Injection Segment by Type
2.2.1 Blood Extraction
2.2.2 Recombine
2.2.3 Human Albumin Injection Sales by Type
2.2.3.1 Global Human Albumin Injection Sales Market Share by Type (2021-2026)
2.2.3.2 Global Human Albumin Injection Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Human Albumin Injection Sale Price by Type (2021-2026)
2.3 Human Albumin Injection Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Human Albumin Injection Sales by Application
2.3.3.1 Global Human Albumin Injection Sale Market Share by Application (2021-2026)
2.3.3.2 Global Human Albumin Injection Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Human Albumin Injection Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Human Albumin Injection Breakdown Data by Company
3.1.1 Global Human Albumin Injection Annual Sales by Company (2021-2026)
3.1.2 Global Human Albumin Injection Sales Market Share by Company (2021-2026)
3.2 Global Human Albumin Injection Annual Revenue by Company (2021-2026)
3.2.1 Global Human Albumin Injection Revenue by Company (2021-2026)
3.2.2 Global Human Albumin Injection Revenue Market Share by Company (2021-2026)
3.3 Global Human Albumin Injection Sale Price by Company
3.4 Key Manufacturers Human Albumin Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Albumin Injection Product Location Distribution
3.4.2 Players Human Albumin Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HUMAN ALBUMIN INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Human Albumin Injection Market Size by Geographic Region (2021-2026)
4.1.1 Global Human Albumin Injection Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Human Albumin Injection Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Human Albumin Injection Market Size by Country/Region (2021-2026)
4.2.1 Global Human Albumin Injection Annual Sales by Country/Region (2021-2026)
4.2.2 Global Human Albumin Injection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Human Albumin Injection Sales Growth
4.4 APAC Human Albumin Injection Sales Growth
4.5 Europe Human Albumin Injection Sales Growth
4.6 Middle East & Africa Human Albumin Injection Sales Growth
5 AMERICAS
5.1 Americas Human Albumin Injection Sales by Country
5.1.1 Americas Human Albumin Injection Sales by Country (2021-2026)
5.1.2 Americas Human Albumin Injection Revenue by Country (2021-2026)
5.2 Americas Human Albumin Injection Sales by Type (2021-2026)
5.3 Americas Human Albumin Injection Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Albumin Injection Sales by Region
6.1.1 APAC Human Albumin Injection Sales by Region (2021-2026)
6.1.2 APAC Human Albumin Injection Revenue by Region (2021-2026)
6.2 APAC Human Albumin Injection Sales by Type (2021-2026)
6.3 APAC Human Albumin Injection Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Human Albumin Injection by Country
7.1.1 Europe Human Albumin Injection Sales by Country (2021-2026)
7.1.2 Europe Human Albumin Injection Revenue by Country (2021-2026)
7.2 Europe Human Albumin Injection Sales by Type (2021-2026)
7.3 Europe Human Albumin Injection Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Human Albumin Injection by Country
8.1.1 Middle East & Africa Human Albumin Injection Sales by Country (2021-2026)
8.1.2 Middle East & Africa Human Albumin Injection Revenue by Country (2021-2026)
8.2 Middle East & Africa Human Albumin Injection Sales by Type (2021-2026)
8.3 Middle East & Africa Human Albumin Injection Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Albumin Injection
10.3 Manufacturing Process Analysis of Human Albumin Injection
10.4 Industry Chain Structure of Human Albumin Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Albumin Injection Distributors
11.3 Human Albumin Injection Customer
12 WORLD FORECAST REVIEW FOR HUMAN ALBUMIN INJECTION BY GEOGRAPHIC REGION
12.1 Global Human Albumin Injection Market Size Forecast by Region
12.1.1 Global Human Albumin Injection Forecast by Region (2027-2032)
12.1.2 Global Human Albumin Injection Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Human Albumin Injection Forecast by Type (2027-2032)
12.7 Global Human Albumin Injection Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Octapharma
13.1.1 Octapharma Company Information
13.1.2 Octapharma Human Albumin Injection Product Portfolios and Specifications
13.1.3 Octapharma Human Albumin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Octapharma Main Business Overview
13.1.5 Octapharma Latest Developments
13.2 CSL Behring
13.2.1 CSL Behring Company Information
13.2.2 CSL Behring Human Albumin Injection Product Portfolios and Specifications
13.2.3 CSL Behring Human Albumin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 CSL Behring Main Business Overview
13.2.5 CSL Behring Latest Developments
13.3 Biotest (UK) Ltd
13.3.1 Biotest (UK) Ltd Company Information
13.3.2 Biotest (UK) Ltd Human Albumin Injection Product Portfolios and Specifications
13.3.3 Biotest (UK) Ltd Human Albumin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Biotest (UK) Ltd Main Business Overview
13.3.5 Biotest (UK) Ltd Latest Developments
13.4 Baxter
13.4.1 Baxter Company Information
13.4.2 Baxter Human Albumin Injection Product Portfolios and Specifications
13.4.3 Baxter Human Albumin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Baxter Main Business Overview
13.4.5 Baxter Latest Developments
13.5 Kedrion Biopharma, Inc.
13.5.1 Kedrion Biopharma, Inc. Company Information
13.5.2 Kedrion Biopharma, Inc. Human Albumin Injection Product Portfolios and Specifications
13.5.3 Kedrion Biopharma, Inc. Human Albumin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Kedrion Biopharma, Inc. Main Business Overview
13.5.5 Kedrion Biopharma, Inc. Latest Developments
13.6 Grifols
13.6.1 Grifols Company Information
13.6.2 Grifols Human Albumin Injection Product Portfolios and Specifications
13.6.3 Grifols Human Albumin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Grifols Main Business Overview
13.6.5 Grifols Latest Developments
13.7 GE HealthCare
13.7.1 GE HealthCare Company Information
13.7.2 GE HealthCare Human Albumin Injection Product Portfolios and Specifications
13.7.3 GE HealthCare Human Albumin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 GE HealthCare Main Business Overview
13.7.5 GE HealthCare Latest Developments
13.8 Bio Products Laboratory
13.8.1 Bio Products Laboratory Company Information
13.8.2 Bio Products Laboratory Human Albumin Injection Product Portfolios and Specifications
13.8.3 Bio Products Laboratory Human Albumin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Bio Products Laboratory Main Business Overview
13.8.5 Bio Products Laboratory Latest Developments
13.9 Green Cross
13.9.1 Green Cross Company Information
13.9.2 Green Cross Human Albumin Injection Product Portfolios and Specifications
13.9.3 Green Cross Human Albumin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Green Cross Main Business Overview
13.9.5 Green Cross Latest Developments
13.10 SK Plasma
13.10.1 SK Plasma Company Information
13.10.2 SK Plasma Human Albumin Injection Product Portfolios and Specifications
13.10.3 SK Plasma Human Albumin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 SK Plasma Main Business Overview
13.10.5 SK Plasma Latest Developments
13.11 Instituto Grifols
13.11.1 Instituto Grifols Company Information
13.11.2 Instituto Grifols Human Albumin Injection Product Portfolios and Specifications
13.11.3 Instituto Grifols Human Albumin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Instituto Grifols Main Business Overview
13.11.5 Instituto Grifols Latest Developments
13.12 Takeda
13.12.1 Takeda Company Information
13.12.2 Takeda Human Albumin Injection Product Portfolios and Specifications
13.12.3 Takeda Human Albumin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Takeda Main Business Overview
13.12.5 Takeda Latest Developments
13.13 Hualan Bio
13.13.1 Hualan Bio Company Information
13.13.2 Hualan Bio Human Albumin Injection Product Portfolios and Specifications
13.13.3 Hualan Bio Human Albumin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Hualan Bio Main Business Overview
13.13.5 Hualan Bio Latest Developments
13.14 Nanyue Biopharmaceuticals
13.14.1 Nanyue Biopharmaceuticals Company Information
13.14.2 Nanyue Biopharmaceuticals Human Albumin Injection Product Portfolios and Specifications
13.14.3 Nanyue Biopharmaceuticals Human Albumin Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Nanyue Biopharmaceuticals Main Business Overview
13.14.5 Nanyue Biopharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Human Albumin Injection Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Human Albumin Injection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Blood Extraction
Table 4. Major Players of Recombine
Table 5. Global Human Albumin Injection Sales by Type (2021-2026) & (K Units)
Table 6. Global Human Albumin Injection Sales Market Share by Type (2021-2026)
Table 7. Global Human Albumin Injection Revenue by Type (2021-2026) & ($ million)
Table 8. Global Human Albumin Injection Revenue Market Share by Type (2021-2026)
Table 9. Global Human Albumin Injection Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Human Albumin Injection Sale by Application (2021-2026) & (K Units)
Table 11. Global Human Albumin Injection Sale Market Share by Application (2021-2026)
Table 12. Global Human Albumin Injection Revenue by Application (2021-2026) & ($ million)
Table 13. Global Human Albumin Injection Revenue Market Share by Application (2021-2026)
Table 14. Global Human Albumin Injection Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Human Albumin Injection Sales by Company (2021-2026) & (K Units)
Table 16. Global Human Albumin Injection Sales Market Share by Company (2021-2026)
Table 17. Global Human Albumin Injection Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Human Albumin Injection Revenue Market Share by Company (2021-2026)
Table 19. Global Human Albumin Injection Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Human Albumin Injection Producing Area Distribution and Sales Area
Table 21. Players Human Albumin Injection Products Offered
Table 22. Human Albumin Injection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Human Albumin Injection Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Human Albumin Injection Sales Market Share Geographic Region (2021-2026)
Table 27. Global Human Albumin Injection Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Human Albumin Injection Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Human Albumin Injection Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Human Albumin Injection Sales Market Share by Country/Region (2021-2026)
Table 31. Global Human Albumin Injection Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Human Albumin Injection Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Human Albumin Injection Sales by Country (2021-2026) & (K Units)
Table 34. Americas Human Albumin Injection Sales Market Share by Country (2021-2026)
Table 35. Americas Human Albumin Injection Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Human Albumin Injection Sales by Type (2021-2026) & (K Units)
Table 37. Americas Human Albumin Injection Sales by Application (2021-2026) & (K Units)
Table 38. APAC Human Albumin Injection Sales by Region (2021-2026) & (K Units)
Table 39. APAC Human Albumin Injection Sales Market Share by Region (2021-2026)
Table 40. APAC Human Albumin Injection Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Human Albumin Injection Sales by Type (2021-2026) & (K Units)
Table 42. APAC Human Albumin Injection Sales by Application (2021-2026) & (K Units)
Table 43. Europe Human Albumin Injection Sales by Country (2021-2026) & (K Units)
Table 44. Europe Human Albumin Injection Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Human Albumin Injection Sales by Type (2021-2026) & (K Units)
Table 46. Europe Human Albumin Injection Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Human Albumin Injection Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Human Albumin Injection Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Human Albumin Injection Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Human Albumin Injection Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Human Albumin Injection
Table 52. Key Market Challenges & Risks of Human Albumin Injection
Table 53. Key Industry Trends of Human Albumin Injection
Table 54. Human Albumin Injection Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Human Albumin Injection Distributors List
Table 57. Human Albumin Injection Customer List
Table 58. Global Human Albumin Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Human Albumin Injection Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Human Albumin Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Human Albumin Injection Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Human Albumin Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Human Albumin Injection Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Human Albumin Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Human Albumin Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Human Albumin Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Human Albumin Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Human Albumin Injection Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Human Albumin Injection Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Human Albumin Injection Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Human Albumin Injection Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Octapharma Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors
Table 73. Octapharma Human Albumin Injection Product Portfolios and Specifications
Table 74. Octapharma Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Octapharma Main Business
Table 76. Octapharma Latest Developments
Table 77. CSL Behring Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors
Table 78. CSL Behring Human Albumin Injection Product Portfolios and Specifications
Table 79. CSL Behring Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. CSL Behring Main Business
Table 81. CSL Behring Latest Developments
Table 82. Biotest (UK) Ltd Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors
Table 83. Biotest (UK) Ltd Human Albumin Injection Product Portfolios and Specifications
Table 84. Biotest (UK) Ltd Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Biotest (UK) Ltd Main Business
Table 86. Biotest (UK) Ltd Latest Developments
Table 87. Baxter Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors
Table 88. Baxter Human Albumin Injection Product Portfolios and Specifications
Table 89. Baxter Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Baxter Main Business
Table 91. Baxter Latest Developments
Table 92. Kedrion Biopharma, Inc. Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Kedrion Biopharma, Inc. Human Albumin Injection Product Portfolios and Specifications
Table 94. Kedrion Biopharma, Inc. Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Kedrion Biopharma, Inc. Main Business
Table 96. Kedrion Biopharma, Inc. Latest Developments
Table 97. Grifols Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors
Table 98. Grifols Human Albumin Injection Product Portfolios and Specifications
Table 99. Grifols Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Grifols Main Business
Table 101. Grifols Latest Developments
Table 102. GE HealthCare Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors
Table 103. GE HealthCare Human Albumin Injection Product Portfolios and Specifications
Table 104. GE HealthCare Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. GE HealthCare Main Business
Table 106. GE HealthCare Latest Developments
Table 107. Bio Products Laboratory Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors
Table 108. Bio Products Laboratory Human Albumin Injection Product Portfolios and Specifications
Table 109. Bio Products Laboratory Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Bio Products Laboratory Main Business
Table 111. Bio Products Laboratory Latest Developments
Table 112. Green Cross Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors
Table 113. Green Cross Human Albumin Injection Product Portfolios and Specifications
Table 114. Green Cross Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Green Cross Main Business
Table 116. Green Cross Latest Developments
Table 117. SK Plasma Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors
Table 118. SK Plasma Human Albumin Injection Product Portfolios and Specifications
Table 119. SK Plasma Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. SK Plasma Main Business
Table 121. SK Plasma Latest Developments
Table 122. Instituto Grifols Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors
Table 123. Instituto Grifols Human Albumin Injection Product Portfolios and Specifications
Table 124. Instituto Grifols Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Instituto Grifols Main Business
Table 126. Instituto Grifols Latest Developments
Table 127. Takeda Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors
Table 128. Takeda Human Albumin Injection Product Portfolios and Specifications
Table 129. Takeda Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Takeda Main Business
Table 131. Takeda Latest Developments
Table 132. Hualan Bio Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors
Table 133. Hualan Bio Human Albumin Injection Product Portfolios and Specifications
Table 134. Hualan Bio Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Hualan Bio Main Business
Table 136. Hualan Bio Latest Developments
Table 137. Nanyue Biopharmaceuticals Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors
Table 138. Nanyue Biopharmaceuticals Human Albumin Injection Product Portfolios and Specifications
Table 139. Nanyue Biopharmaceuticals Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. Nanyue Biopharmaceuticals Main Business
Table 141. Nanyue Biopharmaceuticals Latest Developments
Table 1. Human Albumin Injection Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Human Albumin Injection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Blood Extraction
Table 4. Major Players of Recombine
Table 5. Global Human Albumin Injection Sales by Type (2021-2026) & (K Units)
Table 6. Global Human Albumin Injection Sales Market Share by Type (2021-2026)
Table 7. Global Human Albumin Injection Revenue by Type (2021-2026) & ($ million)
Table 8. Global Human Albumin Injection Revenue Market Share by Type (2021-2026)
Table 9. Global Human Albumin Injection Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Human Albumin Injection Sale by Application (2021-2026) & (K Units)
Table 11. Global Human Albumin Injection Sale Market Share by Application (2021-2026)
Table 12. Global Human Albumin Injection Revenue by Application (2021-2026) & ($ million)
Table 13. Global Human Albumin Injection Revenue Market Share by Application (2021-2026)
Table 14. Global Human Albumin Injection Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Human Albumin Injection Sales by Company (2021-2026) & (K Units)
Table 16. Global Human Albumin Injection Sales Market Share by Company (2021-2026)
Table 17. Global Human Albumin Injection Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Human Albumin Injection Revenue Market Share by Company (2021-2026)
Table 19. Global Human Albumin Injection Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Human Albumin Injection Producing Area Distribution and Sales Area
Table 21. Players Human Albumin Injection Products Offered
Table 22. Human Albumin Injection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Human Albumin Injection Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Human Albumin Injection Sales Market Share Geographic Region (2021-2026)
Table 27. Global Human Albumin Injection Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Human Albumin Injection Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Human Albumin Injection Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Human Albumin Injection Sales Market Share by Country/Region (2021-2026)
Table 31. Global Human Albumin Injection Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Human Albumin Injection Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Human Albumin Injection Sales by Country (2021-2026) & (K Units)
Table 34. Americas Human Albumin Injection Sales Market Share by Country (2021-2026)
Table 35. Americas Human Albumin Injection Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Human Albumin Injection Sales by Type (2021-2026) & (K Units)
Table 37. Americas Human Albumin Injection Sales by Application (2021-2026) & (K Units)
Table 38. APAC Human Albumin Injection Sales by Region (2021-2026) & (K Units)
Table 39. APAC Human Albumin Injection Sales Market Share by Region (2021-2026)
Table 40. APAC Human Albumin Injection Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Human Albumin Injection Sales by Type (2021-2026) & (K Units)
Table 42. APAC Human Albumin Injection Sales by Application (2021-2026) & (K Units)
Table 43. Europe Human Albumin Injection Sales by Country (2021-2026) & (K Units)
Table 44. Europe Human Albumin Injection Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Human Albumin Injection Sales by Type (2021-2026) & (K Units)
Table 46. Europe Human Albumin Injection Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Human Albumin Injection Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Human Albumin Injection Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Human Albumin Injection Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Human Albumin Injection Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Human Albumin Injection
Table 52. Key Market Challenges & Risks of Human Albumin Injection
Table 53. Key Industry Trends of Human Albumin Injection
Table 54. Human Albumin Injection Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Human Albumin Injection Distributors List
Table 57. Human Albumin Injection Customer List
Table 58. Global Human Albumin Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Human Albumin Injection Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Human Albumin Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Human Albumin Injection Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Human Albumin Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Human Albumin Injection Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Human Albumin Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Human Albumin Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Human Albumin Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Human Albumin Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Human Albumin Injection Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Human Albumin Injection Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Human Albumin Injection Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Human Albumin Injection Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Octapharma Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors
Table 73. Octapharma Human Albumin Injection Product Portfolios and Specifications
Table 74. Octapharma Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Octapharma Main Business
Table 76. Octapharma Latest Developments
Table 77. CSL Behring Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors
Table 78. CSL Behring Human Albumin Injection Product Portfolios and Specifications
Table 79. CSL Behring Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. CSL Behring Main Business
Table 81. CSL Behring Latest Developments
Table 82. Biotest (UK) Ltd Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors
Table 83. Biotest (UK) Ltd Human Albumin Injection Product Portfolios and Specifications
Table 84. Biotest (UK) Ltd Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Biotest (UK) Ltd Main Business
Table 86. Biotest (UK) Ltd Latest Developments
Table 87. Baxter Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors
Table 88. Baxter Human Albumin Injection Product Portfolios and Specifications
Table 89. Baxter Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Baxter Main Business
Table 91. Baxter Latest Developments
Table 92. Kedrion Biopharma, Inc. Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Kedrion Biopharma, Inc. Human Albumin Injection Product Portfolios and Specifications
Table 94. Kedrion Biopharma, Inc. Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Kedrion Biopharma, Inc. Main Business
Table 96. Kedrion Biopharma, Inc. Latest Developments
Table 97. Grifols Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors
Table 98. Grifols Human Albumin Injection Product Portfolios and Specifications
Table 99. Grifols Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Grifols Main Business
Table 101. Grifols Latest Developments
Table 102. GE HealthCare Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors
Table 103. GE HealthCare Human Albumin Injection Product Portfolios and Specifications
Table 104. GE HealthCare Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. GE HealthCare Main Business
Table 106. GE HealthCare Latest Developments
Table 107. Bio Products Laboratory Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors
Table 108. Bio Products Laboratory Human Albumin Injection Product Portfolios and Specifications
Table 109. Bio Products Laboratory Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Bio Products Laboratory Main Business
Table 111. Bio Products Laboratory Latest Developments
Table 112. Green Cross Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors
Table 113. Green Cross Human Albumin Injection Product Portfolios and Specifications
Table 114. Green Cross Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Green Cross Main Business
Table 116. Green Cross Latest Developments
Table 117. SK Plasma Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors
Table 118. SK Plasma Human Albumin Injection Product Portfolios and Specifications
Table 119. SK Plasma Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. SK Plasma Main Business
Table 121. SK Plasma Latest Developments
Table 122. Instituto Grifols Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors
Table 123. Instituto Grifols Human Albumin Injection Product Portfolios and Specifications
Table 124. Instituto Grifols Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Instituto Grifols Main Business
Table 126. Instituto Grifols Latest Developments
Table 127. Takeda Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors
Table 128. Takeda Human Albumin Injection Product Portfolios and Specifications
Table 129. Takeda Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Takeda Main Business
Table 131. Takeda Latest Developments
Table 132. Hualan Bio Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors
Table 133. Hualan Bio Human Albumin Injection Product Portfolios and Specifications
Table 134. Hualan Bio Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Hualan Bio Main Business
Table 136. Hualan Bio Latest Developments
Table 137. Nanyue Biopharmaceuticals Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors
Table 138. Nanyue Biopharmaceuticals Human Albumin Injection Product Portfolios and Specifications
Table 139. Nanyue Biopharmaceuticals Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. Nanyue Biopharmaceuticals Main Business
Table 141. Nanyue Biopharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Picture of Human Albumin Injection
Figure 2. Human Albumin Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Albumin Injection Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Human Albumin Injection Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Human Albumin Injection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Human Albumin Injection Sales Market Share by Country/Region (2025)
Figure 10. Human Albumin Injection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Blood Extraction
Figure 12. Product Picture of Recombine
Figure 13. Global Human Albumin Injection Sales Market Share by Type in 2026
Figure 14. Global Human Albumin Injection Revenue Market Share by Type (2021-2026)
Figure 15. Human Albumin Injection Consumed in Hospital
Figure 16. Global Human Albumin Injection Market: Hospital (2021-2026) & (K Units)
Figure 17. Human Albumin Injection Consumed in Clinic
Figure 18. Global Human Albumin Injection Market: Clinic (2021-2026) & (K Units)
Figure 19. Global Human Albumin Injection Sale Market Share by Application (2025)
Figure 20. Global Human Albumin Injection Revenue Market Share by Application in 2026
Figure 21. Human Albumin Injection Sales by Company in 2026 (K Units)
Figure 22. Global Human Albumin Injection Sales Market Share by Company in 2026
Figure 23. Human Albumin Injection Revenue by Company in 2026 ($ millions)
Figure 24. Global Human Albumin Injection Revenue Market Share by Company in 2026
Figure 25. Global Human Albumin Injection Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Human Albumin Injection Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Human Albumin Injection Sales 2021-2026 (K Units)
Figure 28. Americas Human Albumin Injection Revenue 2021-2026 ($ millions)
Figure 29. APAC Human Albumin Injection Sales 2021-2026 (K Units)
Figure 30. APAC Human Albumin Injection Revenue 2021-2026 ($ millions)
Figure 31. Europe Human Albumin Injection Sales 2021-2026 (K Units)
Figure 32. Europe Human Albumin Injection Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Human Albumin Injection Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa Human Albumin Injection Revenue 2021-2026 ($ millions)
Figure 35. Americas Human Albumin Injection Sales Market Share by Country in 2026
Figure 36. Americas Human Albumin Injection Revenue Market Share by Country (2021-2026)
Figure 37. Americas Human Albumin Injection Sales Market Share by Type (2021-2026)
Figure 38. Americas Human Albumin Injection Sales Market Share by Application (2021-2026)
Figure 39. United States Human Albumin Injection Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Human Albumin Injection Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Human Albumin Injection Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Human Albumin Injection Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Human Albumin Injection Sales Market Share by Region in 2026
Figure 44. APAC Human Albumin Injection Revenue Market Share by Region (2021-2026)
Figure 45. APAC Human Albumin Injection Sales Market Share by Type (2021-2026)
Figure 46. APAC Human Albumin Injection Sales Market Share by Application (2021-2026)
Figure 47. China Human Albumin Injection Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Human Albumin Injection Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Human Albumin Injection Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Human Albumin Injection Revenue Growth 2021-2026 ($ millions)
Figure 51. India Human Albumin Injection Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Human Albumin Injection Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Human Albumin Injection Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Human Albumin Injection Sales Market Share by Country in 2026
Figure 55. Europe Human Albumin Injection Revenue Market Share by Country (2021-2026)
Figure 56. Europe Human Albumin Injection Sales Market Share by Type (2021-2026)
Figure 57. Europe Human Albumin Injection Sales Market Share by Application (2021-2026)
Figure 58. Germany Human Albumin Injection Revenue Growth 2021-2026 ($ millions)
Figure 59. France Human Albumin Injection Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Human Albumin Injection Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Human Albumin Injection Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Human Albumin Injection Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Human Albumin Injection Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Human Albumin Injection Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Human Albumin Injection Sales Market Share by Application (2021-2026)
Figure 66. Egypt Human Albumin Injection Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Human Albumin Injection Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Human Albumin Injection Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Human Albumin Injection Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Human Albumin Injection Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Human Albumin Injection in 2026
Figure 72. Manufacturing Process Analysis of Human Albumin Injection
Figure 73. Industry Chain Structure of Human Albumin Injection
Figure 74. Channels of Distribution
Figure 75. Global Human Albumin Injection Sales Market Forecast by Region (2027-2032)
Figure 76. Global Human Albumin Injection Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Human Albumin Injection Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Human Albumin Injection Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Human Albumin Injection Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Human Albumin Injection Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Human Albumin Injection
Figure 2. Human Albumin Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Albumin Injection Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Human Albumin Injection Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Human Albumin Injection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Human Albumin Injection Sales Market Share by Country/Region (2025)
Figure 10. Human Albumin Injection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Blood Extraction
Figure 12. Product Picture of Recombine
Figure 13. Global Human Albumin Injection Sales Market Share by Type in 2026
Figure 14. Global Human Albumin Injection Revenue Market Share by Type (2021-2026)
Figure 15. Human Albumin Injection Consumed in Hospital
Figure 16. Global Human Albumin Injection Market: Hospital (2021-2026) & (K Units)
Figure 17. Human Albumin Injection Consumed in Clinic
Figure 18. Global Human Albumin Injection Market: Clinic (2021-2026) & (K Units)
Figure 19. Global Human Albumin Injection Sale Market Share by Application (2025)
Figure 20. Global Human Albumin Injection Revenue Market Share by Application in 2026
Figure 21. Human Albumin Injection Sales by Company in 2026 (K Units)
Figure 22. Global Human Albumin Injection Sales Market Share by Company in 2026
Figure 23. Human Albumin Injection Revenue by Company in 2026 ($ millions)
Figure 24. Global Human Albumin Injection Revenue Market Share by Company in 2026
Figure 25. Global Human Albumin Injection Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Human Albumin Injection Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Human Albumin Injection Sales 2021-2026 (K Units)
Figure 28. Americas Human Albumin Injection Revenue 2021-2026 ($ millions)
Figure 29. APAC Human Albumin Injection Sales 2021-2026 (K Units)
Figure 30. APAC Human Albumin Injection Revenue 2021-2026 ($ millions)
Figure 31. Europe Human Albumin Injection Sales 2021-2026 (K Units)
Figure 32. Europe Human Albumin Injection Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Human Albumin Injection Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa Human Albumin Injection Revenue 2021-2026 ($ millions)
Figure 35. Americas Human Albumin Injection Sales Market Share by Country in 2026
Figure 36. Americas Human Albumin Injection Revenue Market Share by Country (2021-2026)
Figure 37. Americas Human Albumin Injection Sales Market Share by Type (2021-2026)
Figure 38. Americas Human Albumin Injection Sales Market Share by Application (2021-2026)
Figure 39. United States Human Albumin Injection Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Human Albumin Injection Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Human Albumin Injection Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Human Albumin Injection Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Human Albumin Injection Sales Market Share by Region in 2026
Figure 44. APAC Human Albumin Injection Revenue Market Share by Region (2021-2026)
Figure 45. APAC Human Albumin Injection Sales Market Share by Type (2021-2026)
Figure 46. APAC Human Albumin Injection Sales Market Share by Application (2021-2026)
Figure 47. China Human Albumin Injection Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Human Albumin Injection Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Human Albumin Injection Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Human Albumin Injection Revenue Growth 2021-2026 ($ millions)
Figure 51. India Human Albumin Injection Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Human Albumin Injection Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Human Albumin Injection Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Human Albumin Injection Sales Market Share by Country in 2026
Figure 55. Europe Human Albumin Injection Revenue Market Share by Country (2021-2026)
Figure 56. Europe Human Albumin Injection Sales Market Share by Type (2021-2026)
Figure 57. Europe Human Albumin Injection Sales Market Share by Application (2021-2026)
Figure 58. Germany Human Albumin Injection Revenue Growth 2021-2026 ($ millions)
Figure 59. France Human Albumin Injection Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Human Albumin Injection Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Human Albumin Injection Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Human Albumin Injection Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Human Albumin Injection Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Human Albumin Injection Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Human Albumin Injection Sales Market Share by Application (2021-2026)
Figure 66. Egypt Human Albumin Injection Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Human Albumin Injection Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Human Albumin Injection Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Human Albumin Injection Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Human Albumin Injection Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Human Albumin Injection in 2026
Figure 72. Manufacturing Process Analysis of Human Albumin Injection
Figure 73. Industry Chain Structure of Human Albumin Injection
Figure 74. Channels of Distribution
Figure 75. Global Human Albumin Injection Sales Market Forecast by Region (2027-2032)
Figure 76. Global Human Albumin Injection Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Human Albumin Injection Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Human Albumin Injection Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Human Albumin Injection Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Human Albumin Injection Revenue Market Share Forecast by Application (2027-2032)
